ArticleBMC genomics2004
Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing.
Article in BMC genomics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 43 citations in OpenAlex.
- Expressed sequence tags for bovine muscle satellite cells, myotube formed-cells and adipocyte-like cells.PloS one · 2013Article
- MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data.Nucleic acids research · 2012Article
- Reproducibility and concordance of differential DNA methylation and gene expression in cancer.PloS one · 2012Article
- Potential molecular targeting of splice variants for cancer treatment.Indian journal of experimental biology · 2011Review
- Global regulation of alternative splicing during myogenic differentiation.Nucleic acids research · 2010Article
- A study of alternative splicing in the pig.BMC research notes · 2010Article
- Towards reliable isoform quantification using RNA-SEQ data.BMC bioinformatics · 2010Article
- A mutation in an alternative untranslated exon of hexokinase 1 associated with hereditary motor and sensory neuropathy -- Russe (HMSNR).European journal of human genetics : EJHG · 2009Article
- Differential splicing using whole-transcript microarrays.BMC bioinformatics · 2009Article
- Genome and proteome annotation: organization, interpretation and integration.Journal of the Royal Society, Interface · 2009Review
- Article
- Trans-natural antisense transcripts including noncoding RNAs in 10 species: implications for expression regulation.Nucleic acids research · 2008Article
- Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.BMC genomics · 2008Article
- Annotation of expressed sequence tags for the East African cichlid fish Astatotilapia burtoni and evolutionary analyses of cichlid ORFs.BMC genomics · 2008Article
- A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants.BMC bioinformatics · 2007Article
- Improving gene annotation using peptide mass spectrometry.Genome research · 2007Article
- Discovery of tissue-specific exons using comprehensive human exon microarrays.Genome biology · 2007Article
- Article
- Verification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.BMC genomics · 2006Article
- Quantitative comparison of EST libraries requires compensation for systematic biases in cDNA generation.BMC bioinformatics · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlternative splicing contributes significantly to the complexity of the human transcriptome and proteome. Computational prediction of alternative splice isoforms are usually based on EST sequences that also allow to approximate the expression pattern of the related transcripts. However, the limited number of tissues represented in the EST data as well as the different cDNA construction protocols may influence the predictive capacity of ESTs to unravel tissue-specifically expressed transcripts.
methodsWe predict tissue and tumor specific splice isoforms based on the genomic mapping (SpliceNest) of the EST consensus sequences and library annotation provided in the GeneNest database. We further ascertain the potentially rare tissue specific transcripts as the ones represented only by ESTs derived from normalized libraries. A subset of the predicted tissue and tumor specific isoforms are then validated via RT-PCR experiments over a spectrum of 40 tissue types.
resultsOur strategy revealed 427 genes with at least one tissue specific transcript as well as 1120 genes showing tumor specific isoforms. While our experimental evaluation of computationally predicted tissue-specific isoforms revealed a high success rate in confirming the expression of these isoforms in the respective tissue, the strategy frequently failed to detect the expected restricted expression pattern. The analysis of putative lowly expressed transcripts using normalized cDNA libraries suggests that our ability to detect tissue-specific isoforms strongly depends on the expression level of the respective transcript as well as on the sensitivity of the experimental methods. Especially splice isoforms predicted to be disease-specific tend to represent transcripts that are expressed in a set of healthy tissues rather than novel isoforms.
conclusionsWe propose to combine the computational prediction of alternative splice isoforms with experimental validation for efficient delineation of an accurate set of tissue-specific transcripts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.